

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.24998575 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.24998575 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.90587074 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.90587074 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.39770732 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.25513534 |
| 7 | negative regulation of fibrinolysis (GO:0051918) | 5.68044228 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.66584730 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.66584730 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.66584730 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.59908437 |
| 12 | urea cycle (GO:0000050) | 5.59764103 |
| 13 | urea metabolic process (GO:0019627) | 5.59764103 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.53937701 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.50222130 |
| 16 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.45084916 |
| 17 | protein carboxylation (GO:0018214) | 5.45084916 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.40855421 |
| 19 | regulation of fibrinolysis (GO:0051917) | 5.38784495 |
| 20 | glyoxylate metabolic process (GO:0046487) | 5.37203413 |
| 21 | tryptophan metabolic process (GO:0006568) | 5.34918681 |
| 22 | regulation of plasminogen activation (GO:0010755) | 5.33399256 |
| 23 | * regulation of protein activation cascade (GO:2000257) | 5.33187357 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 5.33122527 |
| 25 | epoxygenase P450 pathway (GO:0019373) | 5.25595589 |
| 26 | cysteine metabolic process (GO:0006534) | 5.24471144 |
| 27 | * complement activation, alternative pathway (GO:0006957) | 5.20212791 |
| 28 | exogenous drug catabolic process (GO:0042738) | 5.14048065 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 5.13022639 |
| 30 | * regulation of complement activation (GO:0030449) | 4.92612334 |
| 31 | intestinal cholesterol absorption (GO:0030299) | 4.91807283 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 4.90902422 |
| 33 | bile acid metabolic process (GO:0008206) | 4.84837515 |
| 34 | homocysteine metabolic process (GO:0050667) | 4.81977815 |
| 35 | reverse cholesterol transport (GO:0043691) | 4.81123958 |
| 36 | omega-hydroxylase P450 pathway (GO:0097267) | 4.80695413 |
| 37 | * regulation of apoptotic cell clearance (GO:2000425) | 4.77813485 |
| 38 | protein-lipid complex remodeling (GO:0034368) | 4.72564142 |
| 39 | macromolecular complex remodeling (GO:0034367) | 4.72564142 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.72564142 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 4.71210333 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.70681170 |
| 43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.69479770 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.63886845 |
| 45 | * regulation of humoral immune response (GO:0002920) | 4.62241044 |
| 46 | aromatic amino acid family metabolic process (GO:0009072) | 4.61047569 |
| 47 | plasma lipoprotein particle clearance (GO:0034381) | 4.58816580 |
| 48 | amino-acid betaine metabolic process (GO:0006577) | 4.55471614 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.54365051 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.54365051 |
| 51 | negative regulation of blood coagulation (GO:0030195) | 4.53660718 |
| 52 | negative regulation of hemostasis (GO:1900047) | 4.53660718 |
| 53 | negative regulation of complement activation (GO:0045916) | 4.50265004 |
| 54 | phospholipid efflux (GO:0033700) | 4.45765887 |
| 55 | alpha-amino acid catabolic process (GO:1901606) | 4.44020143 |
| 56 | lysine catabolic process (GO:0006554) | 4.41082429 |
| 57 | lysine metabolic process (GO:0006553) | 4.41082429 |
| 58 | negative regulation of sterol transport (GO:0032372) | 4.35685911 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 4.35685911 |
| 60 | bile acid and bile salt transport (GO:0015721) | 4.33493209 |
| 61 | positive regulation of blood coagulation (GO:0030194) | 4.24676615 |
| 62 | positive regulation of hemostasis (GO:1900048) | 4.24676615 |
| 63 | protein-lipid complex subunit organization (GO:0071825) | 4.24116076 |
| 64 | cellular ketone body metabolic process (GO:0046950) | 4.21099039 |
| 65 | ethanol metabolic process (GO:0006067) | 4.20286026 |
| 66 | negative regulation of coagulation (GO:0050819) | 4.19778903 |
| 67 | imidazole-containing compound metabolic process (GO:0052803) | 4.19433058 |
| 68 | cholesterol efflux (GO:0033344) | 4.18062471 |
| 69 | fibrinolysis (GO:0042730) | 4.11212456 |
| 70 | glycine metabolic process (GO:0006544) | 4.09526069 |
| 71 | cellular amino acid catabolic process (GO:0009063) | 4.09478157 |
| 72 | cellular glucuronidation (GO:0052695) | 4.07780435 |
| 73 | low-density lipoprotein particle remodeling (GO:0034374) | 4.05431601 |
| 74 | negative regulation of wound healing (GO:0061045) | 4.05372197 |
| 75 | glutamate metabolic process (GO:0006536) | 4.04474607 |
| 76 | indolalkylamine metabolic process (GO:0006586) | 3.99032575 |
| 77 | plasma lipoprotein particle assembly (GO:0034377) | 3.97858029 |
| 78 | opsonization (GO:0008228) | 3.97685461 |
| 79 | ethanol oxidation (GO:0006069) | 3.95197439 |
| 80 | coenzyme catabolic process (GO:0009109) | 3.92397551 |
| 81 | positive regulation of coagulation (GO:0050820) | 3.91904471 |
| 82 | benzene-containing compound metabolic process (GO:0042537) | 3.90686242 |
| 83 | negative regulation of protein activation cascade (GO:2000258) | 3.90343726 |
| 84 | cellular modified amino acid catabolic process (GO:0042219) | 3.90226548 |
| 85 | amine catabolic process (GO:0009310) | 3.89934817 |
| 86 | cellular biogenic amine catabolic process (GO:0042402) | 3.89934817 |
| 87 | serine family amino acid metabolic process (GO:0009069) | 3.89294614 |
| 88 | arginine metabolic process (GO:0006525) | 3.86595166 |
| 89 | phospholipid homeostasis (GO:0055091) | 3.86542672 |
| 90 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.82631689 |
| 91 | blood coagulation, intrinsic pathway (GO:0007597) | 3.79867394 |
| 92 | drug catabolic process (GO:0042737) | 3.79320494 |
| 93 | positive regulation of lipid catabolic process (GO:0050996) | 3.78057631 |
| 94 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.77737450 |
| 95 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.76353904 |
| 96 | acute-phase response (GO:0006953) | 3.75239596 |
| 97 | aldehyde catabolic process (GO:0046185) | 3.73123388 |
| 98 | cholesterol homeostasis (GO:0042632) | 3.72270415 |
| 99 | lipoprotein metabolic process (GO:0042157) | 3.72214463 |
| 100 | * protein activation cascade (GO:0072376) | 3.71237329 |
| 101 | serine family amino acid biosynthetic process (GO:0009070) | 3.70209405 |
| 102 | * complement activation (GO:0006956) | 3.68348456 |
| 103 | negative regulation of lipase activity (GO:0060192) | 3.67869328 |
| 104 | regulation of cholesterol homeostasis (GO:2000188) | 3.67610821 |
| 105 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.67153714 |
| 106 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.67153714 |
| 107 | sterol homeostasis (GO:0055092) | 3.66524755 |
| 108 | drug metabolic process (GO:0017144) | 3.66150599 |
| 109 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.64367270 |
| 110 | plasma lipoprotein particle organization (GO:0071827) | 3.64065665 |
| 111 | ketone body metabolic process (GO:1902224) | 3.63028872 |
| 112 | glucuronate metabolic process (GO:0019585) | 3.60889597 |
| 113 | uronic acid metabolic process (GO:0006063) | 3.60889597 |
| 114 | carboxylic acid catabolic process (GO:0046395) | 3.60831238 |
| 115 | organic acid catabolic process (GO:0016054) | 3.60831238 |
| 116 | protein-lipid complex assembly (GO:0065005) | 3.60116657 |
| 117 | regulation of bile acid biosynthetic process (GO:0070857) | 3.59826616 |
| 118 | acute inflammatory response (GO:0002526) | 3.58637338 |
| 119 | negative regulation of humoral immune response (GO:0002921) | 3.58240198 |
| 120 | short-chain fatty acid metabolic process (GO:0046459) | 3.54466623 |
| 121 | * complement activation, classical pathway (GO:0006958) | 3.53662639 |
| 122 | cytolysis (GO:0019835) | 3.53565641 |
| 123 | cofactor catabolic process (GO:0051187) | 3.53398478 |
| 124 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.52897910 |
| 125 | positive regulation of extracellular matrix organization (GO:1903055) | 3.49407352 |
| 126 | cholesterol transport (GO:0030301) | 3.38663284 |
| 127 | sterol transport (GO:0015918) | 3.38663284 |
| 128 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.32801673 |
| 129 | * regulation of acute inflammatory response (GO:0002673) | 3.29950557 |
| 130 | negative regulation of lipid transport (GO:0032369) | 3.25542154 |
| 131 | response to mercury ion (GO:0046689) | 3.21590404 |
| 132 | positive regulation of steroid metabolic process (GO:0045940) | 3.18688208 |
| 133 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.18018017 |
| 134 | sodium-independent organic anion transport (GO:0043252) | 3.17303652 |
| 135 | intestinal absorption (GO:0050892) | 3.15964592 |
| 136 | proline metabolic process (GO:0006560) | 3.03988254 |
| 137 | oxidative demethylation (GO:0070989) | 3.00978287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.04909897 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.88706280 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.51106419 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.33070335 |
| 5 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.21723444 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.04776030 |
| 7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.83701708 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.00262045 |
| 9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.68815030 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.27050778 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.14940826 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.00434600 |
| 13 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.3409175 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.99223134 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.84543452 |
| 16 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62390590 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.54338076 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53260655 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48258175 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.46449349 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.39351688 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35425037 |
| 23 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.35072743 |
| 24 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.33300131 |
| 25 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.31457408 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.25404579 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.22566913 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.22003262 |
| 29 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.17026830 |
| 30 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16332536 |
| 31 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.12146424 |
| 32 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.11589784 |
| 33 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.07829000 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.04482305 |
| 35 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.02418582 |
| 36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02072465 |
| 37 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01270506 |
| 38 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00202661 |
| 39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99586107 |
| 40 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97541129 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.95735564 |
| 42 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.95534217 |
| 43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.93027210 |
| 44 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91801101 |
| 45 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.91485648 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90589001 |
| 47 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.89297215 |
| 48 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.88234531 |
| 49 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88180296 |
| 50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.84381316 |
| 51 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.83668528 |
| 52 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.83429442 |
| 53 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83163785 |
| 54 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.82875181 |
| 55 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.81394407 |
| 56 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80696134 |
| 57 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.80274059 |
| 58 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79187709 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78657342 |
| 60 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78657342 |
| 61 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.78378590 |
| 62 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.77886539 |
| 63 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76272001 |
| 64 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75400364 |
| 65 | KDM2B_26808549_Chip-Seq_K562_Human | 0.75344054 |
| 66 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.75151567 |
| 67 | * ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.74533803 |
| 68 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73177056 |
| 69 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.72948002 |
| 70 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71462476 |
| 71 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.70087815 |
| 72 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.69982743 |
| 73 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.69517565 |
| 74 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.68605013 |
| 75 | CJUN_26792858_Chip-Seq_BT549_Human | 0.66036924 |
| 76 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.65512223 |
| 77 | TP53_16413492_ChIP-PET_HCT116_Human | 0.65071353 |
| 78 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.65024456 |
| 79 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.64510410 |
| 80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.64432779 |
| 81 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.64183422 |
| 82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.63774162 |
| 83 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.63311083 |
| 84 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.63196498 |
| 85 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62377309 |
| 86 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.62364773 |
| 87 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.61108371 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 0.60719344 |
| 89 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.60473646 |
| 90 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59900634 |
| 91 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.59178228 |
| 92 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59066030 |
| 93 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.58617524 |
| 94 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.58474739 |
| 95 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58435852 |
| 96 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.57737234 |
| 97 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57459306 |
| 98 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.56771865 |
| 99 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.56370813 |
| 100 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55173218 |
| 101 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55000426 |
| 102 | GATA2_19941826_ChIP-Seq_K562_Human | 0.54803798 |
| 103 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.54690474 |
| 104 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.53992454 |
| 105 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53398472 |
| 106 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.53038954 |
| 107 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.50117793 |
| 108 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.49918205 |
| 109 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.49850109 |
| 110 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.49670614 |
| 111 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.47880596 |
| 112 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.47698573 |
| 113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.46602389 |
| 114 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.45849032 |
| 115 | AR_20517297_ChIP-Seq_VCAP_Human | 0.44467052 |
| 116 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.44010467 |
| 117 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.43969120 |
| 118 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.43890617 |
| 119 | CBP_21632823_ChIP-Seq_H3396_Human | 0.43563166 |
| 120 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.43193258 |
| 121 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.42881754 |
| 122 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.42829313 |
| 123 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.42187110 |
| 124 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.42067476 |
| 125 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41689400 |
| 126 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.41581947 |
| 127 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.41325581 |
| 128 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.41311651 |
| 129 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.41311651 |
| 130 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.39435892 |
| 131 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.38459938 |
| 132 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.38200614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.89089394 |
| 2 | MP0005360_urolithiasis | 7.24664036 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.08402209 |
| 4 | MP0005365_abnormal_bile_salt | 5.88308982 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.10851281 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.87217708 |
| 7 | MP0003252_abnormal_bile_duct | 3.75270950 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.62181112 |
| 9 | MP0009840_abnormal_foam_cell | 3.26877055 |
| 10 | MP0005083_abnormal_biliary_tract | 3.15891458 |
| 11 | MP0003195_calcinosis | 2.67764957 |
| 12 | MP0005332_abnormal_amino_acid | 2.66137106 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.64939348 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.48263313 |
| 15 | MP0000609_abnormal_liver_physiology | 2.20887446 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.13622862 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.11899903 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.01483155 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.81972097 |
| 20 | MP0003868_abnormal_feces_composition | 1.65452894 |
| 21 | MP0002254_reproductive_system_inflammat | 1.60534903 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56865060 |
| 23 | MP0001764_abnormal_homeostasis | 1.54862746 |
| 24 | MP0001915_intracranial_hemorrhage | 1.52809639 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 1.51329183 |
| 26 | MP0003122_maternal_imprinting | 1.45790799 |
| 27 | MP0000566_synostosis | 1.44975907 |
| 28 | MP0000604_amyloidosis | 1.36130217 |
| 29 | MP0009697_abnormal_copulation | 1.32872292 |
| 30 | MP0003011_delayed_dark_adaptation | 1.32565657 |
| 31 | MP0005451_abnormal_body_composition | 1.32090667 |
| 32 | MP0004272_abnormal_basement_membrane | 1.31914886 |
| 33 | MP0009643_abnormal_urine_homeostasis | 1.29001736 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 1.28388032 |
| 35 | MP0003186_abnormal_redox_activity | 1.26636658 |
| 36 | MP0000598_abnormal_liver_morphology | 1.20348177 |
| 37 | MP0009764_decreased_sensitivity_to | 1.19360708 |
| 38 | MP0005670_abnormal_white_adipose | 1.14540865 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.14335015 |
| 40 | MP0002132_abnormal_respiratory_system | 1.13184837 |
| 41 | MP0010368_abnormal_lymphatic_system | 1.12532568 |
| 42 | MP0002089_abnormal_postnatal_growth/wei | 1.11618653 |
| 43 | MP0005409_darkened_coat_color | 1.09597020 |
| 44 | MP0005647_abnormal_sex_gland | 1.09294812 |
| 45 | * MP0009763_increased_sensitivity_to | 1.06256136 |
| 46 | MP0003879_abnormal_hair_cell | 1.03339099 |
| 47 | MP0003566_abnormal_cell_adhesion | 1.03300059 |
| 48 | MP0008469_abnormal_protein_level | 0.97729758 |
| 49 | MP0005636_abnormal_mineral_homeostasis | 0.94700435 |
| 50 | MP0004130_abnormal_muscle_cell | 0.94612533 |
| 51 | * MP0009642_abnormal_blood_homeostasis | 0.87755389 |
| 52 | MP0009780_abnormal_chondrocyte_physiolo | 0.85932734 |
| 53 | MP0002933_joint_inflammation | 0.82968153 |
| 54 | MP0003329_amyloid_beta_deposits | 0.80687024 |
| 55 | MP0005376_homeostasis/metabolism_phenot | 0.79114504 |
| 56 | MP0005334_abnormal_fat_pad | 0.78753929 |
| 57 | MP0002078_abnormal_glucose_homeostasis | 0.78269283 |
| 58 | MP0005257_abnormal_intraocular_pressure | 0.78139251 |
| 59 | MP0003690_abnormal_glial_cell | 0.77493962 |
| 60 | MP0000920_abnormal_myelination | 0.76594802 |
| 61 | MP0005408_hypopigmentation | 0.76461130 |
| 62 | MP0002876_abnormal_thyroid_physiology | 0.76228891 |
| 63 | MP0009765_abnormal_xenobiotic_induced | 0.75890306 |
| 64 | MP0003724_increased_susceptibility_to | 0.75305761 |
| 65 | MP0003950_abnormal_plasma_membrane | 0.74122111 |
| 66 | * MP0002971_abnormal_brown_adipose | 0.70619795 |
| 67 | MP0005220_abnormal_exocrine_pancreas | 0.69784480 |
| 68 | MP0006036_abnormal_mitochondrial_physio | 0.68696357 |
| 69 | MP0001756_abnormal_urination | 0.68189587 |
| 70 | MP0008438_abnormal_cutaneous_collagen | 0.67697002 |
| 71 | MP0005535_abnormal_body_temperature | 0.65943786 |
| 72 | MP0005084_abnormal_gallbladder_morpholo | 0.64896178 |
| 73 | MP0009053_abnormal_anal_canal | 0.63782119 |
| 74 | MP0000639_abnormal_adrenal_gland | 0.63289198 |
| 75 | MP0002998_abnormal_bone_remodeling | 0.62945492 |
| 76 | MP0005666_abnormal_adipose_tissue | 0.61556117 |
| 77 | MP0002909_abnormal_adrenal_gland | 0.59256516 |
| 78 | MP0006054_spinal_hemorrhage | 0.58138909 |
| 79 | MP0005375_adipose_tissue_phenotype | 0.57921322 |
| 80 | MP0003075_altered_response_to | 0.57348812 |
| 81 | MP0000003_abnormal_adipose_tissue | 0.56843963 |
| 82 | MP0000858_altered_metastatic_potential | 0.55932398 |
| 83 | * MP0005464_abnormal_platelet_physiology | 0.55880774 |
| 84 | MP0004782_abnormal_surfactant_physiolog | 0.55801384 |
| 85 | MP0002837_dystrophic_cardiac_calcinosis | 0.54792257 |
| 86 | MP0002136_abnormal_kidney_physiology | 0.54545913 |
| 87 | MP0008004_abnormal_stomach_pH | 0.54307863 |
| 88 | MP0005076_abnormal_cell_differentiation | 0.53838528 |
| 89 | MP0004883_abnormal_blood_vessel | 0.53438906 |
| 90 | MP0000767_abnormal_smooth_muscle | 0.52905091 |
| 91 | MP0003632_abnormal_nervous_system | 0.51981646 |
| 92 | MP0005395_other_phenotype | 0.51819947 |
| 93 | MP0005164_abnormal_response_to | 0.51303675 |
| 94 | MP0005266_abnormal_metabolism | 0.51065032 |
| 95 | * MP0005448_abnormal_energy_balance | 0.50792359 |
| 96 | MP0002896_abnormal_bone_mineralization | 0.50132344 |
| 97 | MP0005058_abnormal_lysosome_morphology | 0.49605364 |
| 98 | MP0003638_abnormal_response/metabolism_ | 0.49282289 |
| 99 | MP0006082_CNS_inflammation | 0.48417182 |
| 100 | MP0001881_abnormal_mammary_gland | 0.48093256 |
| 101 | MP0002928_abnormal_bile_duct | 0.47773232 |
| 102 | MP0009115_abnormal_fat_cell | 0.47568603 |
| 103 | MP0005166_decreased_susceptibility_to | 0.46791766 |
| 104 | MP0009384_cardiac_valve_regurgitation | 0.46748741 |
| 105 | MP0002060_abnormal_skin_morphology | 0.46740153 |
| 106 | MP0002168_other_aberrant_phenotype | 0.46298070 |
| 107 | MP0002128_abnormal_blood_circulation | 0.46232609 |
| 108 | MP0005167_abnormal_blood-brain_barrier | 0.45988561 |
| 109 | MP0008873_increased_physiological_sensi | 0.45980773 |
| 110 | MP0008874_decreased_physiological_sensi | 0.45490254 |
| 111 | * MP0000249_abnormal_blood_vessel | 0.45404028 |
| 112 | MP0005377_hearing/vestibular/ear_phenot | 0.45091518 |
| 113 | MP0003878_abnormal_ear_physiology | 0.45091518 |
| 114 | MP0002282_abnormal_trachea_morphology | 0.44618481 |
| 115 | MP0002295_abnormal_pulmonary_circulatio | 0.43634353 |
| 116 | MP0005165_increased_susceptibility_to | 0.43368960 |
| 117 | * MP0003436_decreased_susceptibility_to | 0.43263787 |
| 118 | MP0001845_abnormal_inflammatory_respons | 0.41472641 |
| 119 | MP0005023_abnormal_wound_healing | 0.41263637 |
| 120 | MP0001243_abnormal_dermal_layer | 0.40369814 |
| 121 | MP0003953_abnormal_hormone_level | 0.40292475 |
| 122 | MP0005248_abnormal_Harderian_gland | 0.39426321 |
| 123 | MP0002796_impaired_skin_barrier | 0.37977471 |
| 124 | MP0003300_gastrointestinal_ulcer | 0.37900052 |
| 125 | MP0006035_abnormal_mitochondrial_morpho | 0.37862040 |
| 126 | MP0001853_heart_inflammation | 0.37804468 |
| 127 | MP0010234_abnormal_vibrissa_follicle | 0.36069005 |
| 128 | MP0004185_abnormal_adipocyte_glucose | 0.35649724 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.35066152 |
| 130 | MP0009785_altered_susceptibility_to | 0.34086590 |
| 131 | MP0003453_abnormal_keratinocyte_physiol | 0.33558604 |
| 132 | MP0009672_abnormal_birth_weight | 0.32982902 |
| 133 | MP0005275_abnormal_skin_tensile | 0.32869672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.57975983 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.00060879 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.95854753 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.47473600 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.41386096 |
| 6 | Xanthomatosis (HP:0000991) | 6.23741328 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.12694500 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.54614924 |
| 9 | * Complement deficiency (HP:0004431) | 4.96404574 |
| 10 | Joint hemorrhage (HP:0005261) | 4.91629058 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 4.75170990 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.74395800 |
| 13 | Epidermoid cyst (HP:0200040) | 4.54251465 |
| 14 | Hyperammonemia (HP:0001987) | 4.50577275 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.41398481 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.26791999 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.18970284 |
| 18 | Hyperglycinemia (HP:0002154) | 4.18277121 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.08802020 |
| 20 | Ketosis (HP:0001946) | 4.07329510 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 4.02756637 |
| 22 | Fat malabsorption (HP:0002630) | 3.91127362 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.89624804 |
| 24 | Hyperglycinuria (HP:0003108) | 3.85067412 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.81345729 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.81345729 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.77717471 |
| 28 | Hypercholesterolemia (HP:0003124) | 3.77205482 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.71337391 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.64382875 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.59342818 |
| 32 | * Abnormality of complement system (HP:0005339) | 3.54691407 |
| 33 | Spontaneous abortion (HP:0005268) | 3.40719377 |
| 34 | Myocardial infarction (HP:0001658) | 3.28649484 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.21899905 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 3.20648243 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.19814464 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.17211218 |
| 39 | Purpura (HP:0000979) | 3.15705540 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.02740174 |
| 41 | Skin nodule (HP:0200036) | 3.00939862 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 2.93805403 |
| 43 | Ketoacidosis (HP:0001993) | 2.90912684 |
| 44 | Delayed CNS myelination (HP:0002188) | 2.87308140 |
| 45 | Steatorrhea (HP:0002570) | 2.83494440 |
| 46 | Abnormality of serum amino acid levels (HP:0003112) | 2.82978994 |
| 47 | Abnormality of purine metabolism (HP:0004352) | 2.74438851 |
| 48 | Hypochromic microcytic anemia (HP:0004840) | 2.68749193 |
| 49 | Amyloidosis (HP:0011034) | 2.63741234 |
| 50 | Vascular calcification (HP:0004934) | 2.63131501 |
| 51 | Gingival bleeding (HP:0000225) | 2.59159603 |
| 52 | Metabolic acidosis (HP:0001942) | 2.58368685 |
| 53 | Mitral stenosis (HP:0001718) | 2.53667019 |
| 54 | Acanthocytosis (HP:0001927) | 2.53207457 |
| 55 | Esophageal varix (HP:0002040) | 2.53121275 |
| 56 | Spastic diplegia (HP:0001264) | 2.51581671 |
| 57 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.48642327 |
| 58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.42443807 |
| 59 | Dicarboxylic aciduria (HP:0003215) | 2.42443807 |
| 60 | Lethargy (HP:0001254) | 2.40770999 |
| 61 | Cardiovascular calcification (HP:0011915) | 2.40287015 |
| 62 | Abnormal gallbladder morphology (HP:0012437) | 2.39876468 |
| 63 | Hypoglycemic seizures (HP:0002173) | 2.35662422 |
| 64 | Cholelithiasis (HP:0001081) | 2.35190534 |
| 65 | Gout (HP:0001997) | 2.34267274 |
| 66 | Menorrhagia (HP:0000132) | 2.34236851 |
| 67 | Malnutrition (HP:0004395) | 2.31151883 |
| 68 | Hemorrhage of the eye (HP:0011885) | 2.26806610 |
| 69 | Thrombophlebitis (HP:0004418) | 2.25860877 |
| 70 | Irritability (HP:0000737) | 2.23068792 |
| 71 | Cholecystitis (HP:0001082) | 2.22416767 |
| 72 | Abnormal gallbladder physiology (HP:0012438) | 2.22416767 |
| 73 | Abnormality of carpal bone ossification (HP:0006257) | 2.21955729 |
| 74 | Protrusio acetabuli (HP:0003179) | 2.21929462 |
| 75 | Neonatal onset (HP:0003623) | 2.21105830 |
| 76 | Cerebral aneurysm (HP:0004944) | 2.19192117 |
| 77 | Pancreatitis (HP:0001733) | 2.18889817 |
| 78 | Cerebral edema (HP:0002181) | 2.14934601 |
| 79 | Hydroxyprolinuria (HP:0003080) | 2.05856787 |
| 80 | Abnormality of proline metabolism (HP:0010907) | 2.05856787 |
| 81 | Sensorimotor neuropathy (HP:0007141) | 2.04343439 |
| 82 | Late onset (HP:0003584) | 2.02510590 |
| 83 | Flat acetabular roof (HP:0003180) | 2.01056392 |
| 84 | Abnormality of iron homeostasis (HP:0011031) | 2.00992168 |
| 85 | Vomiting (HP:0002013) | 1.99228922 |
| 86 | Abnormal cartilage morphology (HP:0002763) | 1.98728284 |
| 87 | Generalized aminoaciduria (HP:0002909) | 1.98372366 |
| 88 | * Glomerulonephritis (HP:0000099) | 1.97247748 |
| 89 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95862449 |
| 90 | Arthropathy (HP:0003040) | 1.95007436 |
| 91 | Poikilocytosis (HP:0004447) | 1.93333791 |
| 92 | Osteomalacia (HP:0002749) | 1.92647821 |
| 93 | Abnormality of the Achilles tendon (HP:0005109) | 1.92353443 |
| 94 | Abnormality of the gallbladder (HP:0005264) | 1.92062820 |
| 95 | Enlarged kidneys (HP:0000105) | 1.92002757 |
| 96 | Opisthotonus (HP:0002179) | 1.91184213 |
| 97 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.90932676 |
| 98 | Mucopolysacchariduria (HP:0008155) | 1.90932676 |
| 99 | Brushfield spots (HP:0001088) | 1.90677265 |
| 100 | Facial shape deformation (HP:0011334) | 1.87146336 |
| 101 | Potter facies (HP:0002009) | 1.87146336 |
| 102 | Hypertriglyceridemia (HP:0002155) | 1.86936598 |
| 103 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.85424825 |
| 104 | Epistaxis (HP:0000421) | 1.80951601 |
| 105 | Stroke (HP:0001297) | 1.80857927 |
| 106 | Pulmonary embolism (HP:0002204) | 1.80540377 |
| 107 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79210386 |
| 108 | Alkalosis (HP:0001948) | 1.77864016 |
| 109 | Rickets (HP:0002748) | 1.77367410 |
| 110 | Abnormal tarsal ossification (HP:0008369) | 1.76751207 |
| 111 | Elevated hepatic transaminases (HP:0002910) | 1.73380529 |
| 112 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.72880369 |
| 113 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.72880369 |
| 114 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.72880369 |
| 115 | Arterial tortuosity (HP:0005116) | 1.71830110 |
| 116 | * Nephritis (HP:0000123) | 1.70954968 |
| 117 | Hyperglycemia (HP:0003074) | 1.67704862 |
| 118 | Impaired platelet aggregation (HP:0003540) | 1.66909942 |
| 119 | Abnormal platelet function (HP:0011869) | 1.66909942 |
| 120 | Hypophosphatemic rickets (HP:0004912) | 1.66658192 |
| 121 | Peritonitis (HP:0002586) | 1.66363100 |
| 122 | Abnormal ossification of hand bones (HP:0005921) | 1.65265229 |
| 123 | Increased serum ferritin (HP:0003281) | 1.64338984 |
| 124 | Abnormal delivery (HP:0001787) | 1.63125522 |
| 125 | Back pain (HP:0003418) | 1.61696101 |
| 126 | Abnormal hand bone ossification (HP:0010660) | 1.60879354 |
| 127 | Bifid scrotum (HP:0000048) | 1.60044793 |
| 128 | Vertebral compression fractures (HP:0002953) | 1.59829928 |
| 129 | Joint swelling (HP:0001386) | 1.59269904 |
| 130 | Vascular tortuosity (HP:0004948) | 1.59193549 |
| 131 | Retinal atrophy (HP:0001105) | 1.59023337 |
| 132 | Neurofibrillary tangles (HP:0002185) | 1.58318050 |
| 133 | Small epiphyses (HP:0010585) | 1.57820427 |
| 134 | Polycythemia (HP:0001901) | 1.54987368 |
| 135 | Asymmetry of the thorax (HP:0001555) | 1.52543053 |
| 136 | Glomerulosclerosis (HP:0000096) | 1.51267207 |
| 137 | Coxa vara (HP:0002812) | 1.47614133 |
| 138 | Elevated alkaline phosphatase (HP:0003155) | 1.47077728 |
| 139 | Abnormality of the lumbar spine (HP:0100712) | 1.45672299 |
| 140 | Gangrene (HP:0100758) | 1.44205306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.07111386 |
| 2 | ERN1 | 4.66281115 |
| 3 | FGFR4 | 4.52914948 |
| 4 | SIK1 | 4.42615431 |
| 5 | TAOK3 | 2.93156881 |
| 6 | TRIB3 | 2.62173743 |
| 7 | INSRR | 2.62016589 |
| 8 | PKN2 | 2.47481942 |
| 9 | MST1R | 2.30949083 |
| 10 | ERBB4 | 2.14187845 |
| 11 | TYK2 | 2.00821896 |
| 12 | MAP2K4 | 1.81883056 |
| 13 | PIK3CG | 1.78791505 |
| 14 | FLT3 | 1.77842761 |
| 15 | DDR2 | 1.70254221 |
| 16 | PTK6 | 1.69947501 |
| 17 | LATS1 | 1.64155959 |
| 18 | PIK3CA | 1.56594704 |
| 19 | MAPK11 | 1.56263394 |
| 20 | CDC42BPA | 1.56114518 |
| 21 | EPHB1 | 1.55762385 |
| 22 | CDK12 | 1.49421199 |
| 23 | FGFR2 | 1.47539762 |
| 24 | FRK | 1.42950529 |
| 25 | DAPK2 | 1.40873192 |
| 26 | TGFBR2 | 1.40376998 |
| 27 | NEK9 | 1.39173601 |
| 28 | JAK1 | 1.36468684 |
| 29 | AKT3 | 1.31338994 |
| 30 | KDR | 1.30792361 |
| 31 | TBK1 | 1.29879859 |
| 32 | CAMK1D | 1.29056943 |
| 33 | TYRO3 | 1.27890459 |
| 34 | ABL2 | 1.27435194 |
| 35 | JAK2 | 1.26959246 |
| 36 | EPHA2 | 1.26155353 |
| 37 | LMTK2 | 1.25558726 |
| 38 | EEF2K | 1.23429163 |
| 39 | MAP3K2 | 1.21178052 |
| 40 | RIPK1 | 1.20207718 |
| 41 | WNK4 | 1.19954943 |
| 42 | EPHA3 | 1.19030076 |
| 43 | PRKAA2 | 1.12739616 |
| 44 | PDK2 | 1.12691628 |
| 45 | WNK1 | 1.12324671 |
| 46 | MAP2K3 | 1.11605917 |
| 47 | MAP3K14 | 1.08357657 |
| 48 | MAP3K7 | 1.08289490 |
| 49 | TIE1 | 1.01071135 |
| 50 | MET | 0.99972747 |
| 51 | LATS2 | 0.96686037 |
| 52 | CSK | 0.96487516 |
| 53 | FGFR3 | 0.96384970 |
| 54 | MAP3K10 | 0.94311920 |
| 55 | PDGFRB | 0.93051545 |
| 56 | MAPK4 | 0.88922590 |
| 57 | MAP3K3 | 0.86831053 |
| 58 | GRK6 | 0.84274693 |
| 59 | ERBB2 | 0.83761032 |
| 60 | SMG1 | 0.82765917 |
| 61 | MAPKAPK3 | 0.81279326 |
| 62 | CDK6 | 0.80290796 |
| 63 | PRKCZ | 0.79711517 |
| 64 | IKBKE | 0.79595893 |
| 65 | NTRK1 | 0.77573798 |
| 66 | IRAK3 | 0.75766809 |
| 67 | PTK2 | 0.73810666 |
| 68 | SGK494 | 0.73331195 |
| 69 | SGK223 | 0.73331195 |
| 70 | GSK3A | 0.72349520 |
| 71 | CAMK1G | 0.70837225 |
| 72 | MARK2 | 0.69676116 |
| 73 | MAPK12 | 0.68615285 |
| 74 | PRKACG | 0.67006889 |
| 75 | MYLK | 0.66297165 |
| 76 | NLK | 0.63254223 |
| 77 | NTRK3 | 0.61826868 |
| 78 | PDGFRA | 0.60927889 |
| 79 | PINK1 | 0.59111211 |
| 80 | PRKAA1 | 0.58913807 |
| 81 | CSF1R | 0.57438000 |
| 82 | MAP3K11 | 0.57140126 |
| 83 | SGK3 | 0.56982894 |
| 84 | DYRK1B | 0.54299144 |
| 85 | PDPK1 | 0.54037007 |
| 86 | STK38L | 0.53279349 |
| 87 | RET | 0.52924027 |
| 88 | MAPK15 | 0.51480046 |
| 89 | MAP2K1 | 0.50493073 |
| 90 | CAMK2G | 0.50295099 |
| 91 | SGK1 | 0.49365630 |
| 92 | KSR2 | 0.49199584 |
| 93 | BMX | 0.47777758 |
| 94 | SRC | 0.47758600 |
| 95 | FGR | 0.46901752 |
| 96 | IGF1R | 0.46431641 |
| 97 | MAP3K13 | 0.43830356 |
| 98 | MTOR | 0.43232175 |
| 99 | TTN | 0.42656601 |
| 100 | KIT | 0.42557945 |
| 101 | JAK3 | 0.42227134 |
| 102 | MAP2K6 | 0.41782771 |
| 103 | PRPF4B | 0.41566265 |
| 104 | MAPK7 | 0.41428436 |
| 105 | PRKG1 | 0.40249982 |
| 106 | MELK | 0.39784301 |
| 107 | IRAK1 | 0.39057023 |
| 108 | NEK6 | 0.38887593 |
| 109 | STK38 | 0.38751002 |
| 110 | EGFR | 0.38414917 |
| 111 | PRKCQ | 0.36441249 |
| 112 | MAP3K1 | 0.36157240 |
| 113 | EPHB2 | 0.36018224 |
| 114 | FER | 0.35847253 |
| 115 | TRPM7 | 0.35549817 |
| 116 | ZAP70 | 0.35196021 |
| 117 | MOS | 0.35193284 |
| 118 | MAPK3 | 0.34658707 |
| 119 | PAK2 | 0.34442192 |
| 120 | SIK2 | 0.33582923 |
| 121 | MAP3K6 | 0.33244339 |
| 122 | MAP3K5 | 0.31295799 |
| 123 | GRK1 | 0.31138840 |
| 124 | PDK1 | 0.30705331 |
| 125 | ABL1 | 0.30353828 |
| 126 | ICK | 0.29717070 |
| 127 | MAPKAPK2 | 0.29140835 |
| 128 | HIPK2 | 0.28838546 |
| 129 | BLK | 0.28772409 |
| 130 | PRKD1 | 0.28706345 |
| 131 | PAK4 | 0.28558716 |
| 132 | CDK4 | 0.28445524 |
| 133 | SGK2 | 0.27023074 |
| 134 | CSNK1G1 | 0.26716627 |
| 135 | FGFR1 | 0.26714157 |
| 136 | STK3 | 0.26702774 |
| 137 | DAPK3 | 0.25475914 |
| 138 | PDK3 | 0.24112524 |
| 139 | PDK4 | 0.24112524 |
| 140 | CHUK | 0.23357838 |
| 141 | PAK3 | 0.21946802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.27810378 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.94639590 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.35897104 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33934676 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.11053671 |
| 6 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.90358705 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62808429 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.59661947 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.54759781 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49851816 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.44907562 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39833749 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23765943 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11366673 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.04751857 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 1.98713196 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.96678330 |
| 18 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96412783 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.95605459 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93488542 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93193898 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.90323218 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.89836615 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89055183 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83782598 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76015644 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.71389056 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.69765150 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.63548879 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62119434 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57229642 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56634144 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51013002 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.50530024 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47406665 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39109066 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38914202 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32139322 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28028583 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27979355 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.27202822 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.26897481 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.23174795 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21673961 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.20096346 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17948900 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17931020 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13111659 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.07240541 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96743726 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.95142789 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92551334 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92201139 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88225531 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87133132 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.86303025 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85102617 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84439532 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.82056328 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78800080 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75318322 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67929540 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65423236 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63691394 |
| 65 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.62543633 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61578574 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.52812518 |
| 68 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.44694285 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40401230 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38043046 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34767293 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.32927442 |
| 73 | Mineral absorption_Homo sapiens_hsa04978 | 0.32533631 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.29337609 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24977453 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24317190 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21537097 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20567835 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20083053 |
| 80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.15308347 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14775484 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.14212704 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.11710283 |
| 84 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10143926 |
| 85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.08145911 |
| 86 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.07344766 |
| 87 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.07329494 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.07148098 |
| 89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.03720427 |
| 90 | Focal adhesion_Homo sapiens_hsa04510 | 0.02179723 |
| 91 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2046674 |
| 92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2030265 |
| 93 | Bladder cancer_Homo sapiens_hsa05219 | -0.1981377 |
| 94 | * Pertussis_Homo sapiens_hsa05133 | -0.1926539 |
| 95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1727546 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1618386 |
| 97 | Malaria_Homo sapiens_hsa05144 | -0.1527675 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1518539 |
| 99 | Lysosome_Homo sapiens_hsa04142 | -0.1402351 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1371446 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1252356 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1184777 |
| 103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1183265 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | -0.1014357 |
| 105 | Amoebiasis_Homo sapiens_hsa05146 | -0.0990990 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0975517 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0923699 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0863206 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0739957 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | -0.0518720 |
| 111 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0467735 |
| 112 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | -0.0058831 |

